Search:
   

Friday, July 22, 2016

Equity Trader Alert #2016 - 166
Reverse split in conjunction with Name, Symbol, and CUSIP change for Synta Pharmaceuticals Corp. (SNTA)

Category:

  • Industry Announcement

Markets Impacted:

Contact Information:

Resources:

Synta Pharmaceuticals Corp. (SNTA) has completed a business combination transaction with Madrigal Pharmaceuticals. The company will undergo a one for thirty-five (1-35) reverse split of its common stock as well as a name, symbol, and CUSIP change effective at the open of business on Monday, July 25, 2016.

See details below:

Current Company Name: Synta Pharmaceuticals Corp.
Issue: Common Stock
Current CUSIP: 87162T206
Current Symbol: SNTA
New Company Name: Madrigal Pharmaceuticals, Inc.
New CUSIP: 558868105
New Symbol: MDGL
Ratio of Reverse Split: 1 for 35
Marketplace Effective Date: July 25, 2016

If you would like to register as a market maker in MDGL, contact Nasdaq Trading Services at +1 212 231 5100.

Please follow Nasdaq on Facebook RSS and Twitter.

Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $13 trillion. To learn more, visit: business.nasdaq.com.

View NASDAQTrader.com Mobile